Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the tysabri(r) observational programme in the uk.
Radiologically isolated syndrome: an uncommon finding at a university clinic in a high-prevalence region for multiple sclerosis.
Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.
Anti-myelin antibodies play an important role in the susceptibility to develop PLP-induced EAE.
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosis.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Exercise training improves depressive symptoms in people with multiple sclerosis: Results of a meta-analysis.
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
Inflammatory Cytokines and Physical Activity in Multiple Sclerosis.
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS.
Iron Oxide as an MRI Contrast Agent for Cell Tracking.
Atypical presentation of multiple sclerosis.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Effects of isoxazolo-pyridinone 7e, a potent activator of the nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Acceleration of conduction velocity linked to clustering of nodal components precedes myelination.
Grb2 Is Important for T Cell Development, Th Cell Differentiation, and Induction of Experimental Autoimmune Encephalomyelitis.
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.
Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis.
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
Pages
« first
‹ previous
…
592
593
594
595
596
597
598
599
600
…
next ›
last »